Patents by Inventor Mark Tizard

Mark Tizard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210269800
    Abstract: The present invention relates to new double stranded RNA (dsRNA) structures and their use in gene silencing.
    Type: Application
    Filed: August 2, 2019
    Publication date: September 2, 2021
    Inventors: Neil Andrew SMITH, Ming Bo WANG, Daai ZHANG, Timothy James DORAN, Mark TIZARD, Annapurna Devi ALLU, Ian Kevin GREAVES, Lingling GAO, Jonathan Paul ANDERSON, Robert DE FEYTER
  • Publication number: 20200263174
    Abstract: The present invention relates to new double stranded RNA (dsRNA) structures and their use in gene silencing.
    Type: Application
    Filed: September 17, 2018
    Publication date: August 20, 2020
    Inventors: Neil Andrew SMITH, Ming-Bo WANG, Timothy James DORAN, Mark TIZARD, Annapurna Devi ALLU, Ian Kevin GREAVES, Lingling GAO, Jonathan Paul ANDERSON, Daai ZHANG, Robert DE FEYTER
  • Patent number: 7541181
    Abstract: The invention provides a nucleotide sequence representing a pathogenicity island found in species of pathogenic mycobacteria. The islands are shown as SEQ ID NOS: 3 and 4 and comprises several open reading frames encoding polypeptides. These polypeptides and their use in diagnosis and therapy form a further aspect of the invention.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: June 2, 2009
    Inventors: John Hermon-Taylor, Tim Doran, Douglas Millar, Mark Tizard, Mark Loughlin, Nazira Sumar, John Ford
  • Publication number: 20060204521
    Abstract: The invention provides a nucleotide sequence representing a pathogenicity island found in species of pathogenic mycobacteria. The islands are shown as SEQ ID NOS: 3 and 4 and comprises several open reading frames encoding polypeptides. These polypeptides and their use in diagnosis and therapy form a further aspect of the invention.
    Type: Application
    Filed: May 17, 2006
    Publication date: September 14, 2006
    Applicant: St. George's Hospital Medical School
    Inventors: John Hermon-Taylor, Tim Doran, Douglas Millar, Mark Tizard, Mark Loughlin, Nazira Sumar, John Ford
  • Publication number: 20040260078
    Abstract: The invention provides a nucleotide sequence representing a pathogenicity island found in species of pathogenic mycobacteria. The islands are shown as SEQ ID NOS: 3 and 4 and comprises several open reading frames encoding polypeptides. These polypeptides and their use in diagnosis and therapy form a further aspect of the invention.
    Type: Application
    Filed: March 22, 2004
    Publication date: December 23, 2004
    Applicant: St. George's Hospital Medical School
    Inventors: John Hermon-Taylor, Tim Doran, Douglas Millar, Mark Tizard, Mark Loughlin, Nazira Sumar, John Ford
  • Patent number: 6156322
    Abstract: The invention provides a nucleotide sequence representing a pathogenicity island found in species of pathogenic mycobacteria. The islands are shown as SEQ ID NOs: 3 and 4 and comprises several open reading frames encoding polypeptides. These polypeptides and their use in diagnosis and therapy form a further aspect of the invention.
    Type: Grant
    Filed: September 16, 1998
    Date of Patent: December 5, 2000
    Assignee: St. George's Hospital Medical School
    Inventors: John Hermon-Taylor, Tim Doran, Douglas Millar, Mark Tizard, Mark Loughlin, Nazira Sumar, John Ford